Epigenomics AG Demonstrates Feasibility of Convenient Blood Test for Lung Cancer Detection in Clinical Study
June 27, 2007 02:46 ET
|
Epigenomics AG
-- Positive clinical data from collaborative study with Charite
-- Potential to address a high unmet medical need as no IVD test for
lung cancer available thus far
-- Successful clinical...
QIAGEN and Epigenomics Expand Successful Partnership
May 29, 2007 02:32 ET
|
Epigenomics AG
BERLIN and VENLO, The Netherlands, May 29, 2007 (PRIME NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) (Prime Standard:QIA) and Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX) today...
Ad Hoc: Epigenomics AG Expands Partnership With QIAGEN N.V.
May 29, 2007 02:30 ET
|
Epigenomics AG
BERLIN and SEATTLE, May 29, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) today announced that it further expanded the existing strategic partnership with QIAGEN N.V. (Nasdaq:QGEN)...
New Clinical Data Further Support Applicability of Epigenomics' Lead Biomarker For Colorectal Cancer Screening
May 21, 2007 03:10 ET
|
Epigenomics AG
BERLIN and SEATTLE, May 21, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) and Prof. Dr. Matthias Ebert, Professor of Clinical and Molecular Gastroenterology at the University Hospital of the...
Epigenomics AG Enters Into R&D Collaboration With Myriad Genetics Inc. to Discover DNA Methylation Biomarkers
May 09, 2007 02:10 ET
|
Epigenomics AG
BERLIN and SEATTLE, May 9, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company developing products based on DNA methylation, has entered into an R&D...
Ad Hoc: Epigenomics AG Announces Capital Increase
May 03, 2007 14:30 ET
|
Epigenomics AG
BERLIN and SEATTLE, May 3, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) today announced that its Management Board and Supervisory Board decided to increase the company's share capital...
Epigenomics AG: Significant Improvement in Colorectal Cancer Early Detection by DNA Methylation Test Through Modified Assay Procedure
April 18, 2007 02:42 ET
|
Epigenomics AG
BERLIN and SEATTLE, April 18, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company developing tests based on DNA methylation, yesterday presented the most...
Epigenomics Optimizes Workflow for Testing its Proprietary Biomarkers for the Early Detection of Cancer in Blood Plasma
April 13, 2007 02:48 ET
|
Epigenomics AG
BERLIN and SEATTLE, April 13, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company developing tests based on DNA methylation, yesterday presented research...
Clinical Data's Cogenics Division Enters Into Alliance With Epigenomics for DNA Methylation Services
April 12, 2007 08:18 ET
|
Epigenomics AG
NEWTON, Mass. and BERLIN, Germany, April 12, 2007 (PRIME NEWSWIRE) -- Clinical Data, Inc. (NASDAQ:CLDA) and Epigenomics AG (Other OTC:EPGNF) (FSE:ECX) today announced an agreement to offer...
Epigenomics AG to Present Most Recent Data on Colorectal Cancer Screening at the Upcoming AACR Annual Meeting 2007
April 11, 2007 02:58 ET
|
Epigenomics AG
BERLIN and SEATTLE, April 11, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company developing tests based on DNA methylation, will present the most recent...